233 related articles for article (PubMed ID: 32249312)
1. Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction.
Wang L; Kempton JB; Jiang H; Jodelka FM; Brigande AM; Dumont RA; Rigo F; Lentz JJ; Hastings ML; Brigande JV
Nucleic Acids Res; 2020 May; 48(9):5065-5080. PubMed ID: 32249312
[TBL] [Abstract][Full Text] [Related]
2. Direct Delivery of Antisense Oligonucleotides to the Middle and Inner Ear Improves Hearing and Balance in Usher Mice.
Lentz JJ; Pan B; Ponnath A; Tran CM; Nist-Lund C; Galvin A; Goldberg H; Robillard KN; Jodelka FM; Farris HE; Huang J; Chen T; Zhu H; Zhou W; Rigo F; Hastings ML; Géléoc GSG
Mol Ther; 2020 Dec; 28(12):2662-2676. PubMed ID: 32818431
[TBL] [Abstract][Full Text] [Related]
3. Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness.
Lentz JJ; Jodelka FM; Hinrich AJ; McCaffrey KE; Farris HE; Spalitta MJ; Bazan NG; Duelli DM; Rigo F; Hastings ML
Nat Med; 2013 Mar; 19(3):345-50. PubMed ID: 23380860
[TBL] [Abstract][Full Text] [Related]
4. Rescue of Outer Hair Cells with Antisense Oligonucleotides in Usher Mice Is Dependent on Age of Treatment.
Ponnath A; Depreux FF; Jodelka FM; Rigo F; Farris HE; Hastings ML; Lentz JJ
J Assoc Res Otolaryngol; 2018 Feb; 19(1):1-16. PubMed ID: 29027038
[TBL] [Abstract][Full Text] [Related]
5. Rescue of peripheral vestibular function in Usher syndrome mice using a splice-switching antisense oligonucleotide.
Vijayakumar S; Depreux FF; Jodelka FM; Lentz JJ; Rigo F; Jones TA; Hastings ML
Hum Mol Genet; 2017 Sep; 26(18):3482-3494. PubMed ID: 28633508
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse.
Depreux FF; Wang L; Jiang H; Jodelka FM; Rosencrans RF; Rigo F; Lentz JJ; Brigande JV; Hastings ML
Nucleic Acids Res; 2016 Nov; 44(20):9519-9529. PubMed ID: 27683224
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide therapy rescues disruptions in organization of exploratory movements associated with Usher syndrome type 1C in mice.
Donaldson TN; Jennings KT; Cherep LA; McNeela AM; Depreux FF; Jodelka FM; Hastings ML; Wallace DG
Behav Brain Res; 2018 Feb; 338():76-87. PubMed ID: 29037661
[TBL] [Abstract][Full Text] [Related]
8. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C.
Verpy E; Leibovici M; Zwaenepoel I; Liu XZ; Gal A; Salem N; Mansour A; Blanchard S; Kobayashi I; Keats BJ; Slim R; Petit C
Nat Genet; 2000 Sep; 26(1):51-5. PubMed ID: 10973247
[TBL] [Abstract][Full Text] [Related]
9. Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction.
Hastings ML; Jones TA
Neurotherapeutics; 2019 Apr; 16(2):348-359. PubMed ID: 30972560
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.
Reiners J; Nagel-Wolfrum K; Jürgens K; Märker T; Wolfrum U
Exp Eye Res; 2006 Jul; 83(1):97-119. PubMed ID: 16545802
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of otospiralin, a novel inner ear protein, causes hair cell degeneration and deafness.
Delprat B; Boulanger A; Wang J; Beaudoin V; Guitton MJ; Ventéo S; Dechesne CJ; Pujol R; Lavigne-Rebillard M; Puel JL; Hamel CP
J Neurosci; 2002 Mar; 22(5):1718-25. PubMed ID: 11880501
[TBL] [Abstract][Full Text] [Related]
12. Null mutation of alpha1D Ca2+ channel gene results in deafness but no vestibular defect in mice.
Dou H; Vazquez AE; Namkung Y; Chu H; Cardell EL; Nie L; Parson S; Shin HS; Yamoah EN
J Assoc Res Otolaryngol; 2004 Jun; 5(2):215-26. PubMed ID: 15357422
[TBL] [Abstract][Full Text] [Related]
13. Deafness and retinal degeneration in a novel USH1C knock-in mouse model.
Lentz JJ; Gordon WC; Farris HE; MacDonald GH; Cunningham DE; Robbins CA; Tempel BL; Bazan NG; Rubel EW; Oesterle EC; Keats BJ
Dev Neurobiol; 2010 Mar; 70(4):253-67. PubMed ID: 20095043
[TBL] [Abstract][Full Text] [Related]
14. Lineage analysis of the late otocyst stage mouse inner ear by transuterine microinjection of a retroviral vector encoding alkaline phosphatase and an oligonucleotide library.
Jiang H; Wang L; Beier KT; Cepko CL; Fekete DM; Brigande JV
PLoS One; 2013; 8(7):e69314. PubMed ID: 23935981
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel ENU-generated myosin VI mutant mouse strain with congenital deafness and vestibular dysfunction.
Williams LH; Miller KA; Dahl HH; Manji SS
Hear Res; 2013 May; 299():53-62. PubMed ID: 23485424
[TBL] [Abstract][Full Text] [Related]
16. A Novel ENU-Induced Mutation in Myo6 Causes Vestibular Dysfunction and Deafness.
Wong EY; Xu CY; Brahmachary M; Xu PX
PLoS One; 2016; 11(5):e0154984. PubMed ID: 27171474
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy in Mouse Models of Deafness and Balance Dysfunction.
Wang L; Kempton JB; Brigande JV
Front Mol Neurosci; 2018; 11():300. PubMed ID: 30210291
[TBL] [Abstract][Full Text] [Related]
18. Auditory and vestibular defects in the circling (ci2) rat mutant.
Kaiser A; Fedrowitz M; Ebert U; Zimmermann E; Hedrich HJ; Wedekind D; Löscher W
Eur J Neurosci; 2001 Oct; 14(7):1129-42. PubMed ID: 11683905
[TBL] [Abstract][Full Text] [Related]
19. Hair cells in the inner ear of the pirouette and shaker 2 mutant mice.
Beyer LA; Odeh H; Probst FJ; Lambert EH; Dolan DF; Camper SA; Kohrman DC; Raphael Y
J Neurocytol; 2000 Apr; 29(4):227-40. PubMed ID: 11276175
[TBL] [Abstract][Full Text] [Related]
20. Vestibular system in infants with hereditary nonsyndromic deafness.
Zagólski O
Otol Neurotol; 2007 Dec; 28(8):1053-5. PubMed ID: 17898670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
